Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2019, Article ID 9385397, 7 pages
https://doi.org/10.1155/2019/9385397
Research Article

Impact of Patient Beliefs on Blood Pressure Control in the General Population: Findings from the Population-Based STAAB Cohort Study

1Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany
2Comprehensive Heart Failure Center, University of Würzburg, Germany
3Department of Medicine I, University Hospital Würzburg, Germany
4Clinical Trial Unit, University Hospital Würzburg, Germany

Correspondence should be addressed to Peter U. Heuschmann; ed.grubzreuw-inu@nnamhcsueh.retep

Received 23 January 2019; Revised 19 June 2019; Accepted 7 July 2019; Published 28 July 2019

Academic Editor: Tomohiro Katsuya

Copyright © 2019 Theresa Tiffe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Diederichs and H. Neuhauser, “The incidence of hypertension and its risk factors in the German adult population: results from the German National Health Interview and Examination Survey 1998 and the German Health Interview and Examination Survey for Adults 2008-2011,” Journal of Hypertension, vol. 35, no. 2, pp. 250–258, 2017. View at Publisher · View at Google Scholar
  2. S. Ross, A. Walker, and M. J. MacLeod, “Patient compliance in hypertension: Role of illness perceptions and treatment beliefs,” Journal of Human Hypertension, vol. 18, no. 9, pp. 607–613, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Shiri, “The role of insight into and beliefs about medicines of hypertensive patients,” Cardiovascular Journal of Africa, vol. 18, no. 6, pp. 353–357, 2007. View at Google Scholar
  4. H. M. Phatak and J. Thomas, “Relationships Between Beliefs about Medications and Nonadherence to Prescribed Chronic Medications,” Annals of Pharmacotherapy, vol. 40, no. 10, pp. 1737–1742, 2016. View at Publisher · View at Google Scholar
  5. R. Horne, “Patients' beliefs about treatment: the hidden determinant of treatment outcome?” Journal of Psychosomatic Research, vol. 47, no. 6, pp. 491–495, 1999. View at Google Scholar
  6. M. D. Gagnon, E. Waltermaurer, A. Martin, C. Friedenson, E. Gayle, and D. L. Hauser, “Patient Beliefs Have a Greater Impact Than Barriers on Medication Adherence in a Community Health Center,” The Journal of the American Board of Family Medicine, vol. 30, no. 3, pp. 331–336, 2017. View at Publisher · View at Google Scholar
  7. R. Horne, S. C. E. Chapman, R. Parham, N. Freemantle, A. Forbes, and V. Cooper, “Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework,” PLoS ONE, vol. 8, no. 12, Article ID e80633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Wagner, T. Tiffe, C. Morbach, G. Gelbrich, S. Störk, and P. U. Heuschmann, “Characteristics and Course of Heart Failure Stages A–B and Determinants of Progression – design and rationale of the STAAB cohort study,” European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 468–479, 2017. View at Publisher · View at Google Scholar
  9. R. Horne and J. Weinman, “Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness,” Journal of Psychosomatic Research, vol. 47, no. 6, pp. 555–567, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Horne, J. Weinman, and M. Hankins, “The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication,” Psychology & Health, vol. 14, no. 1, pp. 1–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Figueiras et al., “Patients' illness schemata of hypertension: The role of beliefs for the choice of treatment,” Psychology & Health, vol. 25, no. 4, pp. 507–517, 2010. View at Google Scholar
  12. R. Horne, J. Clatworthy, and M. Hankins, “High adherence and concordance within a clinical trial of antihypertensives,” Chronic Illness, vol. 6, no. 4, pp. 243–251, 2010. View at Publisher · View at Google Scholar
  13. B. Leng, Y. Jin, G. Li, L. Chen, and N. Jin, “Socioeconomic status and hypertension: a meta-analysis,” Journal of Hypertension, vol. 33, no. 2, pp. 221–229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Di Giosia, P. Giorgini, C. A. Stamerra, M. Petrarca, C. Ferri, and A. Sahebkar, “Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension,” Current Atherosclerosis Reports, vol. 20, no. 3, 2018. View at Publisher · View at Google Scholar
  15. G. Mancia, R. Fagard, and K. Narkiewicz, “2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 34, pp. 2159–2219, 2013. View at Publisher · View at Google Scholar
  16. H. B. Hubert, M. Feinleib, P. M. McNamara, and W. P. Castelli, “Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study,” Circulation, vol. 67, no. 5, pp. 968–977, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. Piepoli et al., “2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR),” European Journal of Preventive Cardiology, 2016. View at Google Scholar
  18. C. Diederichs and H. Neuhauser, “Regional variations in hypertension prevalence and management in Germany,” Journal of Hypertension, vol. 32, no. 7, pp. 1405–1414, 2014. View at Publisher · View at Google Scholar
  19. D. Isacson and K. Bingefors, “Attitudes towards drugs--a survey in the general population,” Pharmacy World and Science, vol. 24, no. 3, pp. 104–110, 2002. View at Publisher · View at Google Scholar
  20. K. K. Viktil, H. Frøyland, M. Rogvin, and T. A. Moger, “Beliefs about medicines among Norwegian outpatients with chronic cardiovascular disease,” European Journal of Hospital Pharmacy: Science and Practice, vol. 21, no. 2, pp. 118–120, 2014. View at Publisher · View at Google Scholar
  21. R. Rahmawati and B. Bajorek, “Understanding untreated hypertension from patients’ point of view: A qualitative study in rural Yogyakarta province, Indonesia,” Chronic Illness, vol. 14, no. 3, pp. 228–240, 2017. View at Publisher · View at Google Scholar
  22. B. G. Bokhour et al., “The role of patients' explanatory models and daily-lived experience in hypertension self-management,” Journal of General Internal Medicine, vol. 12, no. 27, pp. 1626–1634, 2012. View at Google Scholar
  23. N. C. Theunissen, D. T. de Ridder, J. M. Bensing, and G. E. Rutten, “Manipulation of patient–provider interaction: discussing illness representations or action plans concerning adherence,” Patient Education and Counseling, vol. 51, no. 3, pp. 247–258, 2003. View at Publisher · View at Google Scholar
  24. D. Meyer, H. Leventhal, and M. Gutmann, “Common-sense models of illness: the example of hypertension,” Journal of Health Psychology, vol. 4, no. 2, pp. 115–135, 1985. View at Google Scholar
  25. M. Wilhelm, W. Rief, and B. K. Doering, “It’s all a matter of necessity and concern: A structural equation model of adherence to antihypertensive medication,” Patient Education and Counseling, vol. 101, no. 3, pp. 497–503, 2018. View at Publisher · View at Google Scholar
  26. D. Scala, E. Menditto, G. Caruso et al., “Are you more concerned about or relieved by medicines? An explorative randomized study of the impact of telephone counseling by pharmacists on patients’ beliefs regarding medicines and blood pressure control,” Patient Education and Counseling, vol. 101, no. 4, pp. 679–686, 2018. View at Publisher · View at Google Scholar
  27. V. Santschi, A. Chiolero, A. L. Colosimo et al., “Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.,” Journal of the American Heart Association, vol. 3, no. 2, p. e000718, 2014. View at Publisher · View at Google Scholar · View at Scopus